ASF Alport Patient Registry
Launched by ALPORT SYNDROME FOUNDATION · Jul 24, 2024
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
The ASF Alport Syndrome Registry is a research project aimed at gathering important information about Alport syndrome, a genetic condition that affects the kidneys and can lead to kidney disease. This registry is open to anyone living with Alport syndrome in the United States and its territories, regardless of their age or the stage of their condition. To participate, individuals need to have a confirmed diagnosis, which can be done through genetic testing, a kidney biopsy, or an assessment from a medical professional. Parents or guardians can enroll their children under 18, and older teens will need to confirm their participation when they turn 18.
By joining the registry, participants will help researchers learn more about Alport syndrome, which is crucial for developing new treatments and possibly finding a cure. The registry operates securely online, allowing participants to share and update their health information every few months. Privacy is a top priority, as personal details are kept confidential and no sensitive information like social security numbers is collected. This is a great opportunity for individuals with Alport syndrome and their families to contribute to medical research and improve understanding of this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Confirmed diagnosis of Alport syndrome by a certified genetic counselor, treating physician or nephrologist.
- • 2. Signed informed consent/assent must be provided by the subject and/or caregiver (parent/legal guardian) including compliance with the restrictions listed in the informed consent/assent form and in the study protocol. (Separate age-appropriate assent forms are provided for ages 7-12 years and ages 13-17 years.)
- • 3. Must reside in the USA or US territories and outlying islands. (This criterium may change at an as-yet undetermined future date.)
- Exclusion Criteria:
- • \[none\]
About Alport Syndrome Foundation
The Alport Syndrome Foundation (ASF) is a dedicated nonprofit organization committed to advancing research, education, and awareness for Alport syndrome, a genetic condition that leads to kidney disease, hearing loss, and vision impairment. ASF collaborates with researchers, healthcare professionals, and patient advocacy groups to facilitate clinical trials and innovative therapies aimed at improving the quality of life for individuals affected by this condition. Through funding research initiatives and providing resources for patients and families, the foundation strives to drive progress towards effective treatments and ultimately a cure for Alport syndrome.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Scottsdale, Arizona, United States
Patients applied
Trial Officials
Benjamin A Weinstock, PhD
Principal Investigator
Alport Syndrome Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported